Monoline Hits Bottom Line at UBS

Swiss banking giant UBS (NYSE: UBS  ) stepped up to the earnings plate yesterday, only to get tagged by an errant pitch called 'monolines'. (Not to be confused with monorails.) Monoline insurers comprise a group of companies, most notably Ambac (NYSE: ABK  ) and MBIA (NYSE: MBI  ) , that insure the principal and interest behind bonds and securitized debt vehicles.

Banks insured small portions of their debt portfolios to hedge against potential declines in the housing market. But with no market demand for debt, and insufficient reserves in place, the monolines are increasingly exposed to potentially massive losses themselves.

As the banks struggle to bring complicated debt portfolios onto their balance sheets, even these insured debt products must be sold at a loss. So yesterday, UBS introduced the monoline writedown as the latest creation of a financial sector that has pelted investors with a dizzying array of new concepts and parameters to consider.

UBS reported its first-ever annual loss after a truly dismal quarter, in which $11.28 billion disappeared at the stroke of a pen. The monoline charge was only $871 million, less than 5% of the $18.4 billion they've written off to date. As the first of its kind, however, the writedown begs the question of how many more will follow it.

That's true both for UBS and its beleaguered U.S. counterparts, such as Merrill Lynch (NYSE: MER  ) and Citigroup (NYSE: C  ) . For an anxious global marketplace, this newest development hardly calms the waters; UBS shares were punished accordingly yesterday, falling by more than 7.5%.

Not Ben Bernanke, not investors, and not the banks themselves seem to have a handle on how contagious this subprime virus will be. After mutating into the monoline strain, we're watching the horizon for the rumored commercial real estate flu or municipal bond fever. Like the common cold, though, there appears to be no cure ... it just has to run its course. Investors might do well to keep the banks in quarantine a while longer.

Further Foolishness:

Read/Post Comments (0) | Recommend This Article (7)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 579218, ~/Articles/ArticleHandler.aspx, 10/25/2016 4:59:59 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,169.27 -53.76 -0.30%
S&P 500 2,143.16 -8.17 -0.38%
NASD 5,283.40 -26.43 -0.50%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/25/2016 4:04 PM
UBS $13.80 Down -0.05 -0.36%
UBS AG (USA) CAPS Rating: **
ABKFQ.DL $20.40 Down +0.00 +0.00%
Ambac Financial Gr… CAPS Rating: ***
C $49.59 Up +0.01 +0.02%
Citigroup CAPS Rating: ***
MBI $8.20 Up +0.03 +0.37%
MBIA CAPS Rating: **
MER.DL2 $11.64 Down +0.00 +0.00%
Merrill Lynch & Co… CAPS Rating: *